Compare JPC & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JPC | GRDN |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Retail-Drug Stores and Proprietary Stores |
| Sector | Finance | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2003 | 2023 |
| Metric | JPC | GRDN |
|---|---|---|
| Price | $7.67 | $38.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $40.60 |
| AVG Volume (30 Days) | ★ 882.5K | 332.8K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,448,685,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.63 |
| P/E Ratio | ★ N/A | $117.77 |
| Revenue Growth | N/A | ★ 17.93 |
| 52 Week Low | $7.22 | $23.18 |
| 52 Week High | $8.30 | $47.02 |
| Indicator | JPC | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 38.72 | 42.86 |
| Support Level | $7.62 | $37.39 |
| Resistance Level | $7.92 | $40.49 |
| Average True Range (ATR) | 0.06 | 2.05 |
| MACD | -0.00 | -0.29 |
| Stochastic Oscillator | 13.16 | 8.52 |
Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its primary investment objective is to provide high current income, and its secondary investment objective is total return. The fund invests a majority of its assets in preferred securities and other income-producing securities, including hybrid securities such as contingent capital securities, and the rest of its investments are made in other securities, mainly income-oriented securities such as corporate and taxable municipal debt and common equity.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.